These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
8. Hypocholesterolemic and antioxidant properties of 3-(4-hydroxyl)propanoic acid derivatives in high-cholesterol fed rats. Lee MK; Park YB; Moon SS; Bok SH; Kim DJ; Ha TY; Jeong TS; Jeong KS; Choi MS Chem Biol Interact; 2007 Oct; 170(1):9-19. PubMed ID: 17662703 [TBL] [Abstract][Full Text] [Related]
9. Effect of either gamma-tocotrienol or a tocotrienol mixture on the plasma lipid profile in hamsters. Raederstorff D; Elste V; Aebischer C; Weber P Ann Nutr Metab; 2002; 46(1):17-23. PubMed ID: 11914511 [TBL] [Abstract][Full Text] [Related]
10. Antioxidant activity of tocopherols, tocotrienols, and gamma-oryzanol components from rice bran against cholesterol oxidation accelerated by 2,2'-azobis(2-methylpropionamidine) dihydrochloride. Xu Z; Hua N; Godber JS J Agric Food Chem; 2001 Apr; 49(4):2077-81. PubMed ID: 11308370 [TBL] [Abstract][Full Text] [Related]
11. Phosphorus-containing inhibitors of HMG-CoA reductase. 1. 4-[(2-arylethyl)hydroxyphosphinyl]-3-hydroxy-butanoic acids: a new class of cell-selective inhibitors of cholesterol biosynthesis. Karanewsky DS; Badia MC; Ciosek CP; Robl JA; Sofia MJ; Simpkins LM; DeLange B; Harrity TW; Biller SA; Gordon EM J Med Chem; 1990 Nov; 33(11):2952-6. PubMed ID: 2231594 [No Abstract] [Full Text] [Related]
12. Influence of pravastatin, a specific inhibitor of HMG-CoA reductase, on hepatic metabolism of cholesterol. Reihnér E; Rudling M; Ståhlberg D; Berglund L; Ewerth S; Björkhem I; Einarsson K; Angelin B N Engl J Med; 1990 Jul; 323(4):224-8. PubMed ID: 2114543 [TBL] [Abstract][Full Text] [Related]
13. Relationships between lipophilicity and biological activities in a series of indoline-based anti-oxidative acyl-CoA:cholesterol acyltransferase (ACAT) inhibitors. Takahashi K; Kunishiro K; Kasai M; Miike T; Kurahashi K; Shirahase H Arzneimittelforschung; 2008; 58(12):666-72. PubMed ID: 19202739 [TBL] [Abstract][Full Text] [Related]
14. Hypocholesterolemic and hypolipidemic activity of some novel morpholine derivatives with antioxidant activity. Chrysselis MC; Rekka EA; Kourounakis PN J Med Chem; 2000 Feb; 43(4):609-12. PubMed ID: 10691687 [TBL] [Abstract][Full Text] [Related]
15. RPR 107393, a potent squalene synthase inhibitor and orally effective cholesterol-lowering agent: comparison with inhibitors of HMG-CoA reductase. Amin D; Rutledge RZ; Needle SN; Galczenski HF; Neuenschwander K; Scotese AC; Maguire MP; Bush RC; Hele DJ; Bilder GE; Perrone MH J Pharmacol Exp Ther; 1997 May; 281(2):746-52. PubMed ID: 9152381 [TBL] [Abstract][Full Text] [Related]
17. Thiomorpholine Derivatives with Hypolipidemic and Antioxidant Activity. Tooulia KK; Theodosis-Nobelos P; Rekka EA Arch Pharm (Weinheim); 2015 Sep; 348(9):629-34. PubMed ID: 26191791 [TBL] [Abstract][Full Text] [Related]
18. Preservation of endogenous antioxidant activity and inhibition of lipid peroxidation as common mechanisms of antiatherosclerotic effects of vitamin E, lovastatin and amlodipine. Chen L; Haught WH; Yang B; Saldeen TG; Parathasarathy S; Mehta JL J Am Coll Cardiol; 1997 Aug; 30(2):569-75. PubMed ID: 9247534 [TBL] [Abstract][Full Text] [Related]
19. Antioxidative and hypocholesterolemic activities of water-soluble puerarin glycosides in HepG2 cells and in C57 BL/6J mice. Chung MJ; Sung NJ; Park CS; Kweon DK; Mantovani A; Moon TW; Lee SJ; Park KH Eur J Pharmacol; 2008 Jan; 578(2-3):159-70. PubMed ID: 17976573 [TBL] [Abstract][Full Text] [Related]
20. Antioxidants decreases the intensification of low density lipoprotein in vivo peroxidation during therapy with statins. Lankin VZ; Tikhaze AK; Kukharchuk VV; Konovalova GG; Pisarenko OI; Kaminnyi AI; Shumaev KB; Belenkov YN Mol Cell Biochem; 2003 Jul; 249(1-2):129-40. PubMed ID: 12956408 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]